Index Investing News
Thursday, May 29, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Mainz Biomed opens European Oncology Lab in Germany By Investing.com

by Index Investing News
February 6, 2024
in Financial
Reading Time: 2 mins read
A A
0
Home Financial
Share on FacebookShare on Twitter


© Reuters

BERKELEY, Calif. and MAINZ, Germany – Mainz Biomed N.V. (NASDAQ:MYNZ), a company specializing in early cancer detection diagnostics, announced today the opening of its new European Oncology Lab (EOL) in Saarland, Germany. The facility expands the collaboration with Laboratory Dr. Buhlmann and enables the direct ordering of ColoAlert®, Mainz Biomed’s colorectal cancer (CRC) screening test, as a laboratory medical service.

The EOL initiative allows for invoicing to private health insurance companies, a significant development for the estimated 8.7 million individuals with private health insurance in Germany. This change is expected to enhance accessibility to early CRC detection and open new revenue streams for Mainz Biomed.

ColoAlert® utilizes advanced PCR technology to detect molecular-genetic biomarkers in stool samples, offering a non-invasive, sensitive, and specific alternative to traditional fecal occult blood tests. With March being Colorectal Cancer Awareness Month, Mainz Biomed sees this as an opportunity to raise awareness about the importance of early detection.

Mainz Biomed’s business model includes partnerships with third-party labs and distribution partners, sales through an online shop, and services to corporate health programs. The company aims to provide scalable distribution in the U.S. following FDA approval, which is contingent on the ReconAAsense trial’s outcome.

Colorectal cancer is the third most common cancer worldwide, with screening recommendations starting at age 45. Mainz Biomed’s ColoAlert® is positioned to meet a significant market need, given that a substantial portion of the U.S. population remains unscreened.

This news is based on a press release statement from Mainz Biomed N.V.

InvestingPro Insights

As Mainz Biomed N.V. (NASDAQ:MYNZ) focuses on expanding its CRC screening services, the financial health and market sentiment surrounding the company are pivotal to its growth trajectory. According to InvestingPro data, Mainz Biomed currently has a market capitalization of $17.96 million, reflecting the size of the company in the competitive biotech landscape. Despite a significant revenue growth of 109.79% over the last twelve months as of Q3 2023, the company’s operating income margin stands at a negative 3261.86%, indicating substantial expenses relative to its revenue.

InvestingPro Tips suggest that analysts have recently revised their earnings upwards for the upcoming period, hinting at potential optimism in the company’s financial prospects. However, the stock has been under considerable pressure, trading near its 52-week low and showing a price total return of -86.83% over the last year. The RSI indicates that the stock is in oversold territory, which may interest value-seeking investors.

For those considering an investment in Mainz Biomed, additional insights are available on InvestingPro. There are currently 14 more InvestingPro Tips that could help investors make a more informed decision, including an analysis of the company’s cash burn rate and profitability expectations. Interested readers can use coupon code SFY24 to get an additional 10% off a 2-year InvestingPro+ subscription, or SFY241 to get an additional 10% off a 1-year InvestingPro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.



Source link

Tags: BioMedEuropeanGermanyInvestingcomLabMainzOncologyopens
ShareTweetShareShare
Previous Post

$7 Million for 30 Seconds? It’s Worth It at the Super Bowl.

Next Post

Rashi Peripherals IPO opens on Wednesday. What GMP signals ahead of subscription

Related Posts

Nvidia’s CEO blasted Trump coverage that can price the corporate .5 billion—then praised Trump’s ‘daring imaginative and prescient’ minutes later

Nvidia’s CEO blasted Trump coverage that can price the corporate $10.5 billion—then praised Trump’s ‘daring imaginative and prescient’ minutes later

by Index Investing News
May 29, 2025
0

© 2025 Fortune Media IP Restricted. All Rights Reserved. Use of this web site constitutes acceptance of our Phrases of...

Gen Merch Retailer Case Research

Gen Merch Retailer Case Research

by Index Investing News
May 28, 2025
0

Managing unmanifested, big-and-bulky buyer returns is a problem for even the most important retailers. Counting on a single purchaser could...

Bitcoin: This Investor Would By no means Purchase, However He Gave Golden Suggestions That Reinforce The Thesis

Bitcoin: This Investor Would By no means Purchase, However He Gave Golden Suggestions That Reinforce The Thesis

by Index Investing News
May 28, 2025
0

This text was written byComply withGreater than 5 years of expertise in fairness evaluation in LatAm. We offer our shoppers...

India’s development extra steady in FY26 and FY27 as China falters: EY report

India’s development extra steady in FY26 and FY27 as China falters: EY report

by Index Investing News
May 28, 2025
0

India's development is projected to be comparatively extra steady, at 6.2 per cent in FY26 and 6.3 per cent in...

IIP Progress Slows To 2.7% In April

IIP Progress Slows To 2.7% In April

by Index Investing News
May 28, 2025
0

India's industrial output progress slowed to 2.7% in April, as towards the revised progress of three% within the previous month...

Next Post
Rashi Peripherals IPO opens on Wednesday. What GMP signals ahead of subscription

Rashi Peripherals IPO opens on Wednesday. What GMP signals ahead of subscription

Transcript: Tom Hancock, GMO – The Big Picture

Transcript: Tom Hancock, GMO - The Big Picture

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Actual Madrid and England star leaked as EA Sports activities FC 25 cowl star

Actual Madrid and England star leaked as EA Sports activities FC 25 cowl star

July 11, 2024
Denis Villeneuve wakes at night thinking about Blade Runner 2049

Denis Villeneuve wakes at night thinking about Blade Runner 2049

March 4, 2024
Climate Transition Risk in European Equity Markets

Climate Transition Risk in European Equity Markets

March 15, 2024
Tata Group announces Air India merger with Vistara; SIA to get 25% stake

Tata Group announces Air India merger with Vistara; SIA to get 25% stake

November 29, 2022
Invesco Municipal Revenue Fund This fall 2024 Commentary

Invesco Municipal Revenue Fund This fall 2024 Commentary

March 14, 2025
NASCAR storage reacts to lawsuit: ‘It’s one other version of the cleaning soap opera’

NASCAR storage reacts to lawsuit: ‘It’s one other version of the cleaning soap opera’

October 6, 2024
Phoenix’s Office Market Tones Down

Phoenix’s Office Market Tones Down

May 18, 2023
One Higher-Than-Anticipated Quarter Doesn’t Remedy Ericsson’s Issues (NASDAQ:ERIC)

One Higher-Than-Anticipated Quarter Doesn’t Remedy Ericsson’s Issues (NASDAQ:ERIC)

August 18, 2024
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In